The Community Foundation of Noble County has received a grant of $750,000 from Lilly Endowment Inc. through the Community Support Grant component of the ninth phase of its ...
Eli Lilly and Company (NYSE: LLY) is one of the most profitable NYSE stocks to buy right now. In a report released on ...
Two Warsaw Community High School students received full-ride four year scholarships from the Kosciusko County Community ...
Eli Lilly could extend its lead in its core therapeutic area with the launch of two new products next year. The company also ...
For more than two years it had the entirety of the market for weight-loss drugs to itself. By 2023 sales of Wegovy had ...
Even so, in an interview with The Economist, Mr Doustdar sounded confident that Novo can recover. His prescription is to push ...
Shares of Eli Lilly & Co. rose 3.38% to $1,062.19 Monday, on what proved to be an all-around grim trading session for the ...
TipRanks on MSN
Bank of America says market isn’t pricing in Eli Lilly’s (LLY) weight-loss drug dominance
Orforglipron is Eli Lilly’s weight-loss pill, and Bank of America expects it to enter the market in the second half of 2026 ...
The survey showed that while most of the doctors didn’t have top-of-mind awareness of oral semaglutide’s upcoming FDA ...
A federal judicial panel said Monday it would centralize a growing number of lawsuits against Novo Nordisk and Eli Lilly ...
EXCLUSIVE: Eli Craig, the rising genre filmmaker who directed and co-wrote the cult horror comedy Tucker & Dale vs. Evil, has ...
Bank of America sees Eli Lilly's obesity drug growth underestimated, forecasting $3 billion Orfoglipron revenue by 2026 as new therapies expand global market leadership.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback